Retour

Petco Health and Wellness Company, Inc.

Qualité des données : 100%

WOOF

NASDAQ Consumer Cyclical Specialty Retail

2,79 €

▼ 0,10 € (-3,46%)

Cap. Boursière : 793,24M

Fourchette du Jour

2,77 € 2,89 €

Fourchette 52 Semaines

2,24 € 4,51 €

Volume

2 395 113

Moyenne 50J / 200J

2,75 € / 3,10 €

Clôture Précédente

2,89 €

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Consumer Cyclical (610 pairs)

Métrique	Action	Médiane du Secteur
P/E	87,5	11,2
P/B	0,7	1,4
ROE %	0,8	10,7
Net Margin %	0,2	5,1
Rev Growth 5Y %	0,7	8,3
D/E	2,5	0,8

Objectif de Cours des Analystes

Hold

3,59 € +28.7%

Low: 2,18 € High: 4,53 €

P/E Prévisionnel

19,7

BPA Prévisionnel

0,15 €

Croissance BPA (est.)

+0,0%

CA Est.

6 B

Estimations de Bénéfices

Période	BPA Est.	CA Est.	Analystes
FY2030	0,00 € 0,00 € – 0,00 €	6,2 B	2
FY2029	0,30 € 0,21 € – 0,42 €	6,2 B	4
FY2028	0,29 € 0,20 € – 0,36 €	6,1 B	4

Insider Trading Activity

13 transactions

Date	Insider	Type	Shares	Price	Value
Mar 4, 2026	SIMMONS SABRINA Chief Financial Officer	other	190 584	2,65 €	505 048 €
Mar 4, 2026	Insana Giovanni See Remarks	other	24 044	2,65 €	63 717 €
Mar 4, 2026	Romanko Michael See Remarks	other	130 194	2,65 €	345 014 €
Mar 4, 2026	May Holly Chief Human Resources Officer	other	19 758	2,65 €	52 359 €
Nov 18, 2025	Venezia Patrick J Chief Revenue Officer	other	55 249	2,81 €	155 250 €
Oct 15, 2025	May Holly Chief Human Resources Officer	other	41 811	3,55 €	148 429 €
Aug 1, 2025	Anderson Joel D Chief Executive Officer	grant	1 100	2,48 €	2 728 €
Jul 24, 2025	SIMMONS SABRINA Chief Financial Officer	other	17 574	4,36 €	76 623 €
Jul 24, 2025	MOHAN RAJENDRA M Director	grant	43 422	—	—
Jul 24, 2025	Yen Iris Director	grant	43 422	—	—
Jul 24, 2025	BRIGGS GARY S Director	grant	43 422	—	—
May 2, 2025	Anderson Joel D Chief Executive Officer	grant	5 000	2,60 €	13 000 €
Apr 10, 2025	Insana Giovanni See Remarks	other	1 682	3,25 €	5 467 €

Points Clés

Revenue grew 0,66% annually over 5 years — modest growth

ROE of 0,80% is below average

Debt/Equity of 2,46 — high leverage

Generating 186,95M in free cash flow

P/E of 87,50 — premium valuation

Revenue growth is decelerating — 1Y growth trails 5Y average by 3,19%

Croissance

Revenue Growth (5Y)

0,66%

Revenue (1Y)-2,53%

Earnings (1Y)N/A

FCF Growth (3Y)N/A

Qualité

Return on Equity

0,80%

ROIC2,24%

Net Margin0,15%

Op. Margin2,02%

Sécurité

Debt / Equity

2,46

Current Ratio0,90

Interest Coverage0,92

Valorisation

P/E Ratio

87,50

P/B Ratio0,68

EV/EBITDA28,21

Dividend Yield0,00%

All Fundamental Metrics

Growth
Revenue Growth (1Y)	-2,53%	Revenue Growth (3Y)	-2,38%
Earnings Growth (1Y)	N/A	Earnings Growth (3Y)	N/A
Revenue Growth (5Y)	0,66%	Earnings Growth (5Y)	-51,54%
Profitability
Revenue (TTM)	5,96B	Net Income (TTM)	9,07M
ROE	0,80%	ROA	0,18%
Gross Margin	38,67%	Operating Margin	2,02%
Net Margin	0,15%	Free Cash Flow (TTM)	186,95M
ROIC	2,24%	FCF Growth (3Y)	N/A
Safety
Debt / Equity	2,46	Current Ratio	0,90
Interest Coverage	0,92	Dividend Yield	0,00%
Valuation
P/E Ratio	87,50	P/B Ratio	0,68
P/S Ratio	0,13	PEG Ratio	-0,76
EV/EBITDA	28,21	Dividend Yield	0,00%
Market Cap	793,24M	Enterprise Value	3,40B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric	FY2025	FY2024	FY2023	FY2022	FY2021
Revenue	5,96B	6,12B	6,26B	6,04B	5,81B
Net Income	9,07M	-101,82M	-1,28B	90,80M	164,42M
EPS (Diluted)	0,03	-0,37	-4,78	0,34	0,62
Gross Profit	2,31B	2,32B	2,35B	2,43B	2,43B
Operating Income	120,43M	7,05M	-1,18B	225,56M	266,07M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric	FY2025	FY2024	FY2023	FY2022	FY2021
Total Assets	5,17B	5,19B	5,36B	6,61B	6,50B
Total Liabilities	4,01B	4,08B	4,18B	4,23B	4,24B
Shareholders' Equity	1,16B	1,11B	1,18B	2,38B	2,27B
Total Debt	2,86B	2,96B	3,04B	3,13B	3,05B
Cash & Equivalents	256,74M	165,76M	125,43M	201,90M	211,60M
Current Assets	1,02B	973,62M	951,74M	1,02B	1,07B
Current Liabilities	1,13B	1,14B	1,11B	1,02B	1,05B